Our Opinion
Recently Viewed
Clear AllValue Research Rating
Our Opinion
Riskometer
Very High
₹21.1651 -0.40%
As on 18-Mar-2026
As per SEBI's Riskometer.
Split between different types of investments
Split between categories of Equity investments
We have shifted from our proprietary CapRank classification system to SEBI’s market cap classification system with effect from 14 Jan, 2026.
|
Fund name
|
Rating |
Our Opinion |
Risk
|
Return (%) |
|
Expense Ratio (%)
|
|---|---|---|---|---|---|---|
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan
|
|
|
Very High
|
loading... |
0.52 |
|
|
|
Very High
|
loading... |
0.21 |
|||
 |
|
Very High
|
loading... |
1.04 |
||
 |
|
Very High
|
loading... |
0.91 |
||
|
|
Very High
|
loading... |
1.29 |
₹175 Cr
--
100
1
100
6
About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan is a equity mutual fund scheme of Edelweiss Mutual Fund. Launched on October 26, 2020, it is currently managed by Bhavesh Jain. The fund has an expense ratio of 0.52% with an overall AUM (Assets Under Management) of ₹175 Cr.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. Being passively managed, it replicates the portfolio of its chosen benchmark index. The fund allows minimum lumpsum investment of ₹100 and minimum SIP of ₹100.
Investment Strategy
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Suitability
Nobody should invest in Pharma funds in our opinion, because:
If you still choose to invest:
Capital Gains Taxation
Disclaimer: The tax information has been prepared on a best-effort basis using information available in the public domain and other sources that Value Research considers reliable. This is not meant as tax advice, and we advise you to consult your tax advisor before making any decision. Value Research takes no responsibility and assumes no liability for any loss or damage arising from any investment or redemption decision based on this information.
Dividend Taxation
Subscribers of Value Research Fund Advisor can conveniently invest in the low-cost direct plan of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan through the Value Research Fund Advisor website.
Alternatively, mutual funds can also be purchased directly from the respective fund house’s website. For example, Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan can be bought from the Edelweiss Mutual Fund website. In such a case, if you are investing in multiple funds from different fund houses, you will need to transact separately on each fund house’s website.
The third option is to invest offline, by seeking assistance from a mutual fund distributor. Most banks also act as mutual fund distributors, and you can approach your bank for help in completing your investment.
The latest declared NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan, is ₹21.1651 as of 19-Mar-2026.
| Company | Percentage of Portfolio |
|---|---|
|
11.25
|
|
|
6.01
|
|
|
5.73
|
|
|
5.69
|
|
|
5.17
|
Over the past five years, Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan has delivered an annualised return of 15.23% as of 19-Mar-2026.
The minimum investment required to start investing in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan is ₹100 for the lump sum option and ₹100 for the SIP (Systematic Investment Plan) option.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.